July 2020, ISSUE #6

ICGEB in the news

Whilst COVID has impacted on many of us, much has also been achieved over the last six months; not least the successful completion of several PhDs, including the first by videoconference. Dr. Samson Musonerimana (below), from the Bacteriology lab, also our first alumnus from Burundi, obtained his PhD via the SISSA in early June.

From the Director-General
On the first anniversary of his mandate as Director-General, Lawrence Banks takes a moment to thank all for the support and dedication shown during the last 12 months. Clearly, recent events have made some of these actions more complex, however, ICGEB’s collective response to the pandemic has been wonderful, and many of our Members have expressed complete satisfaction with the levels of support we have been able to provide during this time. Our scientists have risen to the challenges of the COVID crisis and we are seeing major rewards coming from our activities, providing services and skills, advancing clinical trials, and the development of novel diagnostics.
Read more

ICGEB Alumni 
We launch our reference page for our vast Alumni network - over 3000 individuals from more than 60 countries around the globe.
Read more

Former "Biosafety" Group offers broad portfolio to decision-makers.
Virology-Emerging Viruses Group Leader joins ICGEB Cape Town.
Vacancy for HTS Group Leader, Trieste, Italy.

For ESOF and Trieste Next Science Fairs in September 2020, ICGEB's public engagement model "Science & the City" returns.
Read more

CRP Grants
Almost 600 applications, over 100 COVID-related, from across 52 Member States have been received during the last call for Grants.
Read more

Off the press

Overcoming major hurdles in tuberculosis control
Read about the latest study from the Cellular Immunology lab in Delhi in Nature Communications proposing that targeting MSCs can have a major impact on tuberculosis prevention and cure. 
Read more

ICGEB studies for Phase-II clinical trial for treatment of COVID-19 patients
Amongst the many projects and studies underway at ICGEB, studies conducted in collaboration with Italy and India prove instrumental in intiating Phase II clinical trial on AQCH as potential treatment for COVID-19 patients.
Read more

ICGEB and TWAS/UNESCO Strengthen their Partnership
Through The World Academy of Sciences in Italy, an Agreement is signed to build capacity in biotechnology and related fields worldwide, through grant proposals and exchange programmes.
Read more
Copyright © 2020 International Centre for Genetic Engineering and Biotechnology, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.